ReviewFrontiers in endocrinology2025
Advancements in imaging research in thyroid-associated ophthalmopathy.
Review in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid-associated ophthalmopathy (TAO), a sight-threatening ocular condition intricately associated with autoimmune thyroid diseases, is the most common orbital disorder among adults. Accurate assessment of TAO is crucial for effective clinical management. However, the current evaluation system is hindered by significant subjectivity and a lack of standardized objective criteria, thereby complicating the pursuit of precise and individualized treatment strategies. Imaging techniques are integral to the clinical management of TAO, as they provide detailed anatomical visualization of the orbit and reflect underlying pathophysiological changes. This article reviews the applications of three prevalent imaging modalities-ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI)-in the diagnosis and management of TAO. We examine their respective advantages, limitations, and roles in disease diagnosis, staging, and evaluation of therapeutic efficacy, with the aim of providing a scientific basis for the optimization of clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.